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Abstract
Five novel tigliane-type diterpenes, stelleracins A–E (3–7), a novel flavanone dimer,
chamaeflavone A (8), and six known compounds were isolated from roots of Stellera
chamaejasme. Their structures were elucidated by extensive spectroscopic analyses. The isolated
compounds were evaluated for anti-HIV activity in MT4 cells. New compounds 3–5 showed
potent anti-HIV activity (EC90 0.00056–0.0068 μM) and relatively low or no cytotoxicity (IC50
4.4–17.2 μM). These new compounds represent promising new leads for development into anti-
AIDS clinical trial candidates.
Stellera chamaejasme L. (Thymelaeaceae) is a toxic perennial plant that grows at high
altitudes in China and Nepal. Its roots have been used in Traditional Chinese Medicine as an
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emulgent, anthelmintic, and dermatological agent. During our ongoing chemical
investigations of Nepalese medicinal plants, a MeOH extract of S. chamaejasme showed
potent anti-HIV activity. Investigation of the chemical constituents of this extract resulted in
the isolation of eight daphnane-type diterpenes.1 Two of these compounds, stelleralide A
and gnidimacrin, showed extremely potent anti-HIV activity (EC90 0.40 nM) with relatively
low cytotoxicity (IC50 4.3 μM) in MT4 cells.1 Herein, we report a further phytochemical
investigation of S. chamaejasme, including the isolation and structural determination of five
novel tigliane-type diterpenes (3–7), a novel flavanone dimer (8), and six known
compounds; stellerarin (1)2, 12-O-benzoylphorbol 13-octanoate (2),3 (−)-chamaejasmenin B
(9),4,5 (+)-chamaejasmenin C (10),4,5 1,5-diphenyl-2(E)-penten-1-one (11),6,7 and 1-(ω-
feruloyldocosanoyl)glycerol (12).8 The anti-HIV activity of compounds 1–12 was also
evaluated in our study.
RESULTS AND DISCUSSION
A MeOH extract from roots of S. chamaejasme collected in Nepal was partitioned between
EtOAc and H2O. The EtOAc fraction was fractionated by ODS and silica gel column
chromatography, as well as preparative HPLC, to afford seven tigliane-type diterpenes (1–
7), three flavanone dimers (8–10), and two phenolic compounds (11 and 12).
New compounds 3–7 were obtained as white powders, and their 1H and 13C NMR spectra
showed characteristic resonances for the gem-dimethyl cyclopropane moiety of tigliane-type
diterpenes (Table 1). A comparison of the NMR data of stelleracin A (3), and stelleracin B
(4) with those of the known compounds 1 and 2 indicated that the four compounds had the
same structures, except for the 13-acyl moiety.
The molecular formula of 3 was determined as C37H48O8 by HR-FAB-MS. Thus,
compound 3 has two fewer hydrogen atoms than 1, suggesting the presence of a decenoate
moiety in 3. The olefinic position in this moiety was established at C-4′, based on HMBC
correlations from δH 2.45 (H2-2′) and 2.38 (H2-3′) to δC 176.0 (C-1′), as well as 1H -1H
COSY correlations between δH 2.38 (H2-3′) and 5.33 (H-4′). The coupling constant
between the olefinic protons was 10.5 Hz, indicating a cis relationship, and accordingly, the
13-acyl moiety in 3 was assigned as 4Z-decenoate.
The molecular formula of 4 (C37H46O8 from HR-FAB-MS) contained two fewer hydrogen
atoms than that of 3, indicative of a decadienoate 13-acyl moiety. The 1H NMR spectrum
included resonances at δH 5.29 (1H, dt, J = 11.0, 7.5 Hz) and 5.34–5.44 (3H, m) for four
olefinic protons, which had 1H-1H COSY correlations with H2-9′, H2-6′ and H2-3′. Based
on these data, the two double bonds were assigned at C-4′ and C-7′. The orientations of
both olefins were established as cis, based on the chemical shifts of C-3′, C-6′ and C-9′ (δC
22.4, 25.5 and 20.5, respectively). Thus, the 13-acyl moiety in 4 was fully determined as 4Z,
7Z-decadienoate.
The molecular formula of stelleracin C (5) was determined as C35H46O9 from HR-FAB-MS.
Thus, compound 5 contains one more oxygen atom than 2, which is consistent with the
presence of an additional hydroxy group in 3. Accordingly, the C-5 methylene resonances at
δH 2.50, 2.60 and δC 38.9 in the 1H and 13C NMR spectra of 2 were replaced by
hydroxymethylene resonances at δH 4.38 and δC 71.7 in 5. A hydroxy moiety at C-5 was
further confirmed by HMBC correlations from δH 5.73 (H-7) and 3.06 (H-10) to δC 71.7
(C-5). The β-orientation of this hydroxy moiety was deduced from a ROESY correlation
between δH 3.06 (H-10) and 4.38 (H-5).
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The molecular formula of stelleracin D (6) was determined by HR-FAB-MS as C37H50O10,
and contains two more oxygen atoms than that of 1. A comparison of the 1H and 13C NMR
spectroscopic data of 6 and 1 revealed large differences in the B-ring resonances. From
detailed analyses of 2D NMR spectroscopic data, the olefinic proton resonance at δH 6.42 in
6 was assigned to H-5 based on HMBC correlations with δC 206.2 (C-3), 57.3 (C-10) and
66.5 (C-20). Thus, 6 contains a Δ5,6 olefin moiety. In addition, the oxymethine proton
resonance at δH 4.81 in 6 was assigned to C-7, based on sequential 1H-1H COSY
correlations between δH 1.70 (H-14), 2.94 (H-8) and 4.81 (H-7), and HMBC correlations
from H-7 to δC 75.0 (C-9), 31.8 (C-14) and 66.5 (C-20). Based on the molecular formula
and the chemical shift of the C-7 resonance at δC 83.1, the presence of a hydroperoxy
moiety at C-7 was determined. The β-orientation of this moiety was established from
ROESY correlations between H-7/H-10 and H-7/H-14.
Stelleracin E (7) and 6 had superimposable 1H and 13C resonances, except for those of the
C-13 acyl moiety. The acyl group in 7 was established as octanoate, based on the molecular
formula of C35H46O10 and the integrated values of the relevant 1H and 13C NMR
resonances.
Chamaeflavone A (8) was isolated as a white powder, [α]D22 −319.0 (c 0.11, MeOH). Its
molecular formula was determined as C32H26O10 by positive-ion HRFABMS, and was the
same as that of (−)-chamaejasmenin B (9). Compound 8, 9, and 10 had similar 1H and 13C
resonance patterns, suggesting that 8 is also a 3,3″ biflavanone. Based on ROESY
correlations between 7-OCH3/H-6, H-8, and 4′-OCH3/H-3′, H-5′, two methoxy moieties
were present in the same flavanone monomer at C-7 and C-4′. Two fragment peaks at m/z
299 and 271 in the FABMS spectrum also supported this conclusion. The trans relationships
of both H-2/H-3 and H-2″ H-3″ were determined from their coupling constant values (12.0
Hz) by 1H NMR decoupling experiments, and contrasted with the cis relationships of the
same hydrogens in 9 and 10 (coupling constant values of 0 Hz). In the CD spectrum, a
negative Cotton effect at 311 nm and positive Cotton effect at 287 nm were consistent with
2R and 2″ R configurations.
The newly isolated compounds (1–12) were evaluated for anti-HIV-1 activity against NL4-3
virus in MT4 lymphocytes. The anti-HIV EC90 values, defined as the compound
concentration that inhibited HIV-1 replication by 90%, are summarized in Table 3.
Diterpenes 1, 2, and 3 were the most potent compounds, with comparable anti-HIV EC90
values of 0.50, 0.56, and 0.66 nM, respectively. All three compounds also demonstrated
relatively low cytotoxicity (IC50 4.4–5.1 μM). Structurally, these three compounds differ
only in the C-13 ester substituent (decanoate in 1, octanoate in 2, and 4Z-decenoate in 3).
Compounds 4 and 5 showed lower, but still significant, anti-HIV potency with EC90 values
of 6.8 and 3.8 nM, respectively. Compound 5 has a β-hydroxy group at C-5, while the more
potent 1, 2, and 3 are unsubstituted at this position. Compound 4 showed lower anti-HIV
potency, and has a 4Z,7Z-decadienoate ester rather than the less rigid ester side chains in 1,
2, and 3. Compounds 6 and 7 with a C-7 hydroperoxy moiety and a Δ5,6 rather than Δ6,7
olefin (as in compounds 1–5) showed significantly decreased anti-HIV activity with EC90
values of 0.49 and 1.52 μM, respectively. From the preliminary SAR, we can conclude that,
in addition to the C-13 ester substituent, the B-ring also plays a critical role in the anti-HIV
activity of tigliane-type diterpenes. Finally, the new flavanone dimer 8 and known phenolic
compound 12 showed marginal anti-HIV activity with EC90 values of 4.21 and 3.63 μM,
respectively.
In conclusion, seven tigliane-type diterpenes (1–7), three flavanone dimers (8–10), and two
phenolic compounds (11 and 12) were isolated from roots of Stellera chamaejasme L. Six
compounds, stelleracins A–E (3–7) and chamaeflavone A (8), were identified for the first
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time. Three compounds (1, 2, and 3) exhibited potent anti-HIV EC90 values of less than 1
nM. The relevant structural pharmacophores were the ester side chain at C-13 and the
substitution/unsaturation pattern at C-5 to C-7.
The tigliane-type diterpenes described in this study share some structural similarity to
prostratin (12-deoxyphorbol-13-acetate) and DPP (12-deoxyphorbol-13-phenylacetate), as
well as our previously discovered daphnane-type diterpenes,1 stelleralide A and
gnidimacrin. The anti-HIV-1 activity of prostratin, DPP, and gnidimacrin is due, at least in
part, to an ability to activate protein kinase C and down-regulate HIV-1 cellular receptors,
CD4 and chemokine receptors, such as coreceptor CCR5.9–12 Due to their structural
similarity, the new compounds’ extremely potent anti-R5 HIV-1 activity likely results from
the same mechanisms. Although gnidimacrin is a potent inhibitor of many HIV-1 R5
viruses, it was essentially inactive against X4 or dual tropic HIV-1 replication in peripheral
blood mononuclear cells (PBMCs).12 Therefore, it is likely that these new compounds will
also be inactive under the same conditions.
EXPERIMENTAL SECTION
General Experimental Procedures
The UV spectra were obtained with a Hitachi U-2800 spectrophotometer, and the IR spectra
were measured with a Hitachi DFT/IR 460 (KBr disk) spectrometer. Optical rotations were
measured with a Hitachi DIP-1000 polarimeter in a 0.5 dm cell. The 1H and 13C NMR
measurements were recorded using a Varian XL-400 NMR spectrometer with TMS as the
internal reference, and chemical shifts are expressed in δ (ppm). FABMS and HRFABMS
were conducted using JEOL JMS-AX505 HA and JMS-700 M Station mass spectrometers.
Silica gel (Kanto Chemical Corporation) and ODS (Senshu Scientific Co., Ltd.) were used
for column chromatography. For HPLC, a Waters 515 HPLC system, equipped with Shodex
RI-72 refractive index and Shimadzu SPD-10AV UV detectors, was used. TLC was carried
out on Kieselgel 60 F254 Art.5715 (E. Merck) and RP-18 F254 Art.15389 (E. Merck).
Plant Material
The roots of S. chamaejasme were collected from Chele (Alt. 3115m) to Shyammochem
(Alt. 3755m), upper Mustang, Mustang District, Nepal in July 2002, and identified by Dr.
Takahide Kurosawa (Faculty of Symbiotic System Science, Fukushima University). A plant
specimen [LOM-SP020729(047)] is deposited in the herbarium of the University of Tokyo.
Extraction and isolation
Roots of S. chamaejasme (4.2 kg) were extracted with MeOH. The methanolic extract was
concentrated (840.2 g), suspended in H2O, and then partitioned successively with EtOAc.
The EtOAc layer was evaporated under reduced pressure below 40 °C to give a residue
(471.6 g), which was passed over an ODS column, and washed with a gradient of MeOH-
H2O to give eight fractions (1–8). Fractions 2 and 3 were purified by repeated RP-HPLC to
give 8 (15.6 mg), 9 (27.7 mg), 10 (348.4 mg), 11 (88.6 mg), and 12 (1.9 mg). Fraction 4 was
purified by repeated RP-HPLC to give 1 (48.6 mg), 2 (114.3 mg), 3 (27.4 mg), 4 (5.6 mg), 5
(7.4 mg), 6 (2.2 mg), and 7 (2.0 mg).
Stelleracin A (3)—white powder; [α]D23 +2.5 (c 0.13, MeOH); UV (MeOH) λmax (log ε)
230 (4.31) nm; CD (c 2.19 × 10−5, MeOH) Δε24 +0.77 (307), 0 (285), −4.8 (258), 0 (241),
+24.1 (225); IR (KBr) νmax 3413, 2925, 1720, 1711, 1629 cm−1; 1H NMR (CDCl3, 400
MHz) and 13C NMR (CDCl3, 100 MHz), see Table 1; positive-ion FABMS m/z 621 [M +
H]+, 643 [M + Na]+; positive-ion m/z HRFABMS 643.3270 [M+Na]+(calcd for
C37H48O8Na, 643.3242).
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Stelleracin B (4)—white powder; [α]D23 +2.3 (c 0.14, MeOH); UV (MeOH) λmax (log ε)
230 (4.33) nm; CD (c 2.26 × 10−5, MeOH) Δε24 (nm) +1.4 (301), 0 (282), −4.2 (258), 0
(242), +23.9 (225); IR (KBr) νmax 3414, 2925, 1717, 1710, 1629 cm−1; 1H NMR (CDCl3,
400 MHz) and 13C NMR (CDCl3, 100 MHz), see Table 1; positive-ion FABMS m/z 641 [M
+ Na]+; positive-ion HRFABMS m/z 641.3088 [M + Na]+(calcd for C37H46O8Na,
641.3086).
Stelleracin C (5)—white powder; [α]D23 −37 (c 0.12, MeOH); UV (MeOH) λmax (log ε)
230 (4.31) nm; CD (c 1.96 × 10−5, MeOH) Δε24 (nm) +1.2 (302), 0 (280), −9.1 (251), 0
(240), +24.9 (225); IR (KBr) νmax 3404, 2926, 1721, 1712, 1627, 1603 cm−1; 1H NMR
(CDCl3, 400 MHz) and 13C NMR (CDCl3, 100 MHz), see Table 1; positive-ion FABMS m/
z 633 [M + Na]+; positive-ion HRFABMS m/z 633.3055 [M + Na]+ (calcd for C35H46O9Na,
633.3034).
Stelleracin D (6)—white powder, [α]D23 −6.9 (c 0.13, MeOH); UV (MeOH) λmax (log ε)
230 (4.33) nm; CD (c 1.99×10−5, MeOH) Δε24 (nm) −25.5 (243), 0 (230), +22.6 (207); IR
(KBr) νmax 3388, 2925, 1719, 1628, 1603 cm−1; 1H NMR (CDCl3, 400 MHz) and 13C
NMR (CDCl3, 100 MHz), see Table 1; positive-ion FABMS m/z 677 [M + Na]+; negative-
ion FABMS m/z 653[M −H]−; positive-ion HRFABMS m/z 677.3292 [M + Na]+(calcd for
C37H50O10Na, 677.3297).
Stelleracin E (7)—white powder, [α]D22 −38 (c 0.12, MeOH); UV (MeOH) λmax (log ε)
230 (4.26) nm; CD (c 1.91×10−5, MeOH) Δε24 (nm) −15.0 (243), 0 (230), +13.7 (207); IR
(KBr) νmax 3390, 2926, 1719, 1626, 1603 cm−1; 1H NMR (CDCl3, 400 MHz) and 13C
NMR (CDCl3, 100 MHz), see Table 1; positive-ion FABMS m/z 649 [M + Na]+; negative-
ion FABMS m/z 625 [M−H]−; positive-ion HRFABMS m/z 649.2979 [M + Na]+ (calcd for
C35H46O10Na, 649.2984).
Chamaeflavone A (8)—white powder; [α]D22 −319 (c 0.11, MeOH); UV (MeOH) λmax
(log ε) 297 (4.25) nm; CD (c 1.93×10−5, MeOH) Δε24 (nm) −25.4 (311), 0 (299), +32.3
(288), 0 (263), −4.6 (255), 0 (242), −35.4 (218); IR (KBr) νmax 3431, 1638, 1611, 1517,
1459 cm−1; 1H NMR (CDCl3, 400 MHz) and 13C NMR (CDCl3, 100 MHz), see Table 2;
positive-ion FABMS m/z 571 [M + H]+, 593 [M + Na]+, 299 [M - C15H11O5]+, 271 [M-
C17H15O5]+; positive-ion HRFABMS m/z 593.1448 [M + Na]+(calcd for C32H26O10Na,
593.1418).
Anti-HIV Assay
MT4 cells were infected with HIV-1 NL4-3 (multiplicity of infection = 0.001) in the
presence of various concentrations of compounds. Fresh medium, which contained
appropriate concentrations of the compounds, was added to the culture 48 h after infection to
maintain normal cell growth. Virus replication was analyzed on day-4 post-infection using
p24 ELISA kits from Perkin-Elmer. The compound concentration that inhibited HIV-1
replication by 90% (EC90) was calculated by using the biostatistic software Calcusun
(Biosoft).
Cytotoxicity Study
Cytotoxicity of the purified compounds toward MT4 cells was determined by using a cell
viability kit provided by Promega. The CellTiter-Glo Luminescent Cell Viability Assay is a
simple method of determining the viability of the cells in culture based on quantitation of
ATP in metabolically active cells. The CellTiter-Glo reagent was added to MT4 cells that
were cultured parallel to the antiviral assays. The compound concentration that decreased
the cell viability by 50% (IC50) was calculated by using Calcusun (Biosoft).
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Table 2
1H and 13C NMR Spectroscopic Data (δ, CDCl3) for 8
position δC δH (J in Hz)
2 83.4 5.93, d (12.0)a
3 49.7 2.82, dd (12.0,1.5)
4 196.5
5 164.3
6 94.1 5.95, d (2.0)
7 167.9




2′,6′ 129.2 7.04, d (8.0)
3′,5′ 114.3 6.87, d (8.0)
4′ 160.4
7-OCH3 55.7 3.77, s
4′-OCH3 55.4 3.85, s
2″ 83.4 5.92, d (12.0)a
3″ 49.7 2.80 dd (12.0,1.5)
4″
5″
6″ 96.7 5.98, d (2.0)
7″ 164.1




2‴,6‴ 129.4 6.98, d (8.0)
3‴,5‴ 115.7 6.80, d (8.0)
4‴ 156.5
5,5″-OH 11.89, d (14.5)
a,b,c
 Interchangeable signals
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Table 3
Anti-HIV Data of 1–12a










Compounds 9–11 were inactive.
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